title: Antiparallel polypurine phosphorothioate oligonucleotides form stable triplexes with the rat alpha1(I) collagen gene promoter and inhibit transcription in cultured rat fibroblasts.
abstract: The rat alpha1(I) collagen promoter contains a unique polypurine-polypyrimidine sequence between -141 and -200 upstream of the transcription start site. The polypurine sequence from -171 to -200 (C2) is on the coding strand and the adjacent polypurine sequence from -141 to -170 (C1) is on the non-coding strand. Earlier we demonstrated triplex formation with a polypurine 30 nt parallel triplex-forming oligonucleotide (TFO) corresponding to C1 and inhibition of transcriptional activity of the rat alpha1(I) collagen promoter. In the present work we have tested triplex-forming abilities of shorter (18 nt) purine and pyrimidine TFOs in parallel and antiparallel orientation to the C1 purine sequence. Our results show that purine antiparallel TFOs formed triplexes with the highest binding affinities, while pyrimidine oligodeoxyribonucleotides (ODNs) did not show appreciable binding. Phosphorothioate modification of purine TFOs did not significantly reduce binding affinity. We also demonstrate that preformed triplexes are quite stable when precipitated with ethanol and resuspended in water. Further analysis was carried out using two purine phosphorothioate antiparallel TFOs, 158 APS and 164 APS, designed to bind to the promoter region from -141 to -158 and -147 to -164, respectively, which were found to form triplexes even under physiological conditions. DNase I footprinting experiments showed the ability of these TFOs to protect target sequences in the promoter region; both purine sequences (C1 and C2) were protected in the case of 158 APS. Transfection experiments using preformed triplexes with a reporter plasmid containing the collagen promoter sequence showed significant inhibition of transcription when compared with a control phosphorothioate ODN. The effect of 164 APS was greater than that of 158 APS. These results indicate that this triplex strategy could be used in the down-regulation of collagen synthesis in cultured cells and offer the potential to control fibrosis in vivo.
authors.affiliation: Department of Medicine, Division of Cardiology, School of Medicine, University of Missouri-Columbia, Columbia, MO 65212, USA.
authors.forename: J
authors.initials: J
authors.lastname: Joseph
authors.forename: J C
authors.initials: JC
authors.lastname: Kandala
authors.forename: D
authors.initials: D
authors.lastname: Veerapanane
authors.forename: K T
authors.initials: KT
authors.lastname: Weber
authors.forename: R V
authors.initials: RV
authors.lastname: Guntaka
mesh_terms: D000818:Animals; D001483:Base Sequence; D002478:Cells, Cultured; D003094:Collagen / Q000235:genetics*; D004247:DNA / Q000378:metabolism*; D018983:DNA Footprinting; D005347:Fibroblasts / Q000378:metabolism; D008969:Molecular Sequence Data; D009690:Nucleic Acid Conformation; D016376:Oligonucleotides, Antisense / Q000378:metabolism*; D011401:Promoter Regions, Genetic; D051381:Rats; D013873:Thionucleotides / Q000378:metabolism*; D014158:Transcription, Genetic
chemical_list: D016376:Oligonucleotides, Antisense; D013873:Thionucleotides; C051802:triplex DNA; D003094:Collagen; D004247:DNA